Ghent University Academic Bibliography

Advanced

Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease

Karen Heyninck, Andy Wullaert UGent and Rudi Beyaert UGent (2003) BIOCHEMICAL PHARMACOLOGY. 66(8). p.1409-1415
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
BIOCHEMICAL PHARMACOLOGY
Biochem. Pharmacol.
volume
66
issue
8
pages
1409-1415 pages
Web of Science type
Article
Web of Science id
000186120500013
JCR category
PHARMACOLOGY & PHARMACY
JCR impact factor
2.993 (2003)
JCR rank
40/183 (2003)
JCR quartile
1 (2003)
ISSN
0006-2952
DOI
10.1016/S0006-2952(03)00491-X
language
English
UGent publication?
yes
classification
A1
id
211936
handle
http://hdl.handle.net/1854/LU-211936
date created
2004-04-20 16:53:00
date last changed
2016-12-19 15:38:14
@article{211936,
  author       = {Heyninck, Karen and Wullaert, Andy and Beyaert, Rudi},
  issn         = {0006-2952},
  journal      = {BIOCHEMICAL PHARMACOLOGY},
  language     = {eng},
  number       = {8},
  pages        = {1409--1415},
  title        = {Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease},
  url          = {http://dx.doi.org/10.1016/S0006-2952(03)00491-X},
  volume       = {66},
  year         = {2003},
}

Chicago
Heyninck, Karen, Andy Wullaert, and Rudi Beyaert. 2003. “Nuclear Factor-kappa B Plays a Central Role in Tumour Necrosis Factor-mediated Liver Disease.” Biochemical Pharmacology 66 (8): 1409–1415.
APA
Heyninck, K., Wullaert, A., & Beyaert, R. (2003). Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease. BIOCHEMICAL PHARMACOLOGY, 66(8), 1409–1415.
Vancouver
1.
Heyninck K, Wullaert A, Beyaert R. Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease. BIOCHEMICAL PHARMACOLOGY. 2003;66(8):1409–15.
MLA
Heyninck, Karen, Andy Wullaert, and Rudi Beyaert. “Nuclear Factor-kappa B Plays a Central Role in Tumour Necrosis Factor-mediated Liver Disease.” BIOCHEMICAL PHARMACOLOGY 66.8 (2003): 1409–1415. Print.